{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T09:06:14Z","timestamp":1792659974971,"version":"4.5.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["tcmonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Cardiovascular Medicine"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.tcm.2014.08.004","type":"journal-article","created":{"date-parts":[[2014,8,26]],"date-time":"2014-08-26T18:33:10Z","timestamp":1409077990000},"page":"341-349","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["State of the art: Cardiac transplantation"],"prefix":"10.1016","volume":"24","author":[{"given":"Margot K.","family":"Davis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon A.","family":"Hunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tcm.2014.08.004_bib1","first-page":"e240","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines","volume":"128","author":"Yancy","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2014.08.004_bib2","doi-asserted-by":"crossref","first-page":"95.1","DOI":"10.1016\/j.healun.2013.08.006","article-title":"The registry of the international society for heart and lung transplantation: thirtieth official adult heart transplant report\u20142013; focus theme: age","volume":"32","author":"Lund","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.tcm.2014.08.004_bib3","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1056\/NEJM199409223311203","article-title":"The impact of HLA mismatches on the survival of first cadaveric kidney transplants","volume":"331","author":"Held","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tcm.2014.08.004_bib4","unstructured":"UNOS. Organ procurement and transplantation network policy 3.7: allocation of thoracic organs. Available at: http:\/\/optn.transplant.hrsa.gov.laneproxy.stanford.edu\/policiesandbylaws\/policies.asp; 2005 [pp. 1\u201345]."},{"key":"10.1016\/j.tcm.2014.08.004_bib5","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1161\/CIRCULATIONAHA.112.100123","article-title":"Morbidity and mortality in heart transplant candidates supported with mechanical circulatory support: is reappraisal of the current united network for organ sharing thoracic organ allocation policy justified?","volume":"127","author":"Wever-Pinzon","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2014.08.004_bib6","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1056\/NEJMp068048","article-title":"Taking heart\u2013cardiac transplantation past, present, and future","volume":"355","author":"Hunt","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tcm.2014.08.004_bib7","first-page":"393","article-title":"Orthotopic heart and combined heart and lung transplantation with cyclosporin\u2014a immune suppression","volume":"13","author":"Reitz","year":"1981","journal-title":"Transplant Proc"},{"key":"10.1016\/j.tcm.2014.08.004_bib8","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.healun.2007.05.002","article-title":"Lower risk of infectious deaths in cardiac transplant patients receiving basiliximab versus anti-thymocyte globulin as induction therapy","volume":"26","author":"Mattei","year":"2007","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.tcm.2014.08.004_bib9","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.healun.2007.01.006","article-title":"Basiliximab and rabbit anti-thymocyte globulin for prophylaxis of acute rejection after heart transplantation: a non-inferiority trial","volume":"26","author":"Carrier","year":"2007","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.tcm.2014.08.004_bib10","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/tri.12309","article-title":"Steroid-free and steroid withdrawal protocols in heart transplantation: the review of literature","volume":"27","author":"Baraldo","year":"2014","journal-title":"Transpl Int"},{"key":"10.1016\/j.tcm.2014.08.004_bib11","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1111\/j.1399-0012.2008.00887.x","article-title":"Impact of dose reductions on efficacy outcome in heart transplant patients receiving enteric-coated mycophenolate sodium or mycophenolate mofetil at 12 months post-transplantation","volume":"22","author":"Segovia","year":"2008","journal-title":"Clin Transplant"},{"key":"10.1016\/j.tcm.2014.08.004_bib12","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1111\/j.1600-6143.2006.01297.x","article-title":"Mycophenolate mofetil reduces intimal thickness by intravascular ultrasound after heart transplant: reanalysis of the multicenter trial","volume":"6","author":"Kobashigawa","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.tcm.2014.08.004_bib13","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.healun.2005.02.002","article-title":"Three-year results of a randomized, double-blind, controlled trial of mycophenolate mofetil versus azathioprine in cardiac transplant recipients","volume":"24","author":"Eisen","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.tcm.2014.08.004_bib14","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.healun.2006.06.010","article-title":"Mycophenolate mofetil and risk of developing malignancy after orthotopic heart transplantation: analysis of the transplant registry of the International Society for Heart and Lung Transplantation","volume":"25","author":"O\u05f3Neill","year":"2006","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.tcm.2014.08.004_bib15","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1111\/j.1600-6143.2006.01300.x","article-title":"Superior prevention of acute rejection by tacrolimus vs. cyclosporine in heart transplant recipients\u2014a large European trial","volume":"6","author":"Grimm","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.tcm.2014.08.004_bib16","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1111\/j.1600-6143.2006.01290.x","article-title":"Tacrolimus with mycophenolate mofetil (MMF) or sirolimus vs. cyclosporine with MMF in cardiac transplant patients: 1-year report","volume":"6","author":"Kobashigawa","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.tcm.2014.08.004_bib17","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/S1053-2498(98)00060-6","article-title":"A randomized, multicenter comparison of tacrolimus and cyclosporine immunosuppressive regimens in cardiac transplantation: decreased hyperlipidemia and hypertension with tacrolimus","volume":"18","author":"Taylor","year":"1999","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.tcm.2014.08.004_bib18","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/tid.12007","article-title":"Everolimus is associated with a reduced incidence of cytomegalovirus infection following de novo cardiac transplantation","volume":"15","author":"Kobashigawa","year":"2013","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.tcm.2014.08.004_bib19","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1111\/ajt.12181","article-title":"Everolimus versus mycophenolate mofetil in heart transplantation: a randomized, multicenter trial","volume":"13","author":"Eisen","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.tcm.2014.08.004_bib20","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/TP.0b013e3182247ae2","article-title":"Lower malignancy rates in renal allograft recipients converted to sirolimus-based, calcineurin inhibitor-free immunotherapy: 24-month results from the CONVERT trial","volume":"92","author":"Alber\u00fa","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.tcm.2014.08.004_bib21","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1111\/j.1600-6143.2006.01282.x","article-title":"Wound healing complications with de novo sirolimus versus mycophenolate mofetil-based regimen in cardiac transplant recipients","volume":"6","author":"Kuppahally","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.tcm.2014.08.004_bib22","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1056\/NEJMoa074191","article-title":"Tolerance and chimerism after renal and hematopoietic-cell transplantation","volume":"358","author":"Scandling","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tcm.2014.08.004_bib23","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1097\/01.tp.0000174341.49741.8f","article-title":"Results from a human renal allograft tolerance trial evaluating T-cell depletion with alemtuzumab combined with deoxyspergualin","volume":"80","author":"Kirk","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.tcm.2014.08.004_bib24","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/j.healun.2005.03.019","article-title":"Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection","volume":"24","author":"Stewart","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.tcm.2014.08.004_bib25","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.healun.2013.08.011","article-title":"The 2013 International Society for Heart and Lung Transplantation Working Formulation for the standardization of nomenclature in the pathologic diagnosis of antibody-mediated rejection in heart transplantation","volume":"32","author":"Berry","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.tcm.2014.08.004_bib26","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1056\/NEJMoa0912965","article-title":"Gene-expression profiling for rejection surveillance after cardiac transplantation","volume":"362","author":"Pham","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tcm.2014.08.004_bib27","doi-asserted-by":"crossref","first-page":"S203","DOI":"10.1016\/j.healun.2013.01.502","article-title":"Results of a randomized trial of allomap vs heart biopsy in the 1st year after heart transplant early invasive monitoring attenuation through gene expression trial","volume":"32","author":"Kobashigawa","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.tcm.2014.08.004_bib28","doi-asserted-by":"crossref","first-page":"e82153","DOI":"10.1371\/journal.pone.0082153","article-title":"Identification of common blood gene signatures for the diagnosis of renal and cardiac acute allograft rejection","volume":"8","author":"Li","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.tcm.2014.08.004_bib29","first-page":"751","article-title":"Evolution of untreated mild rejection in heart transplant recipients","volume":"11","author":"Lloveras","year":"1992","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.tcm.2014.08.004_bib30","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/ajt.12162","article-title":"A survey of current practice for antibody-mediated rejection in heart transplantation","volume":"13","author":"Chih","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.tcm.2014.08.004_bib31","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/phar.1426","article-title":"Antibody-mediated rejection in kidney transplantation: a review of pathophysiology, diagnosis, and treatment options","volume":"34","author":"Kim","year":"2014","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.tcm.2014.08.004_bib32","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S1053-2498(03)00147-5","article-title":"Analysis of survivors more than 10 years after heart transplantation in the cyclosporine era: Stanford experience","volume":"23","author":"Shiba","year":"2004","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.tcm.2014.08.004_bib33","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1111\/j.1600-6143.2008.02196.x","article-title":"Malignancy after heart transplantation: incidence, prognosis and risk factors","volume":"8","author":"Crespo-Leiro","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1016\/j.tcm.2014.08.004_bib34","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1001\/jama.2011.1592","article-title":"Spectrum of cancer risk among US solid organ transplant recipients","volume":"306","author":"Engels","year":"2011","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.tcm.2014.08.004_bib35","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.healun.2010.05.034","article-title":"The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients","volume":"29","author":"Costanzo","year":"2010","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.tcm.2014.08.004_bib36","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s11899-013-0162-5","article-title":"Post-transplant lymphoproliferative disease (PTLD): risk factors, diagnosis, and current treatment strategies","volume":"8","author":"Al-Mansour","year":"2013","journal-title":"Curr Hematol Malig Rep"},{"key":"10.1016\/j.tcm.2014.08.004_bib37","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1200\/JCO.2009.25.4961","article-title":"Multicenter analysis of 80 solid organ transplantation recipients with post-transplantation lymphoproliferative disease: outcomes and prognostic factors in the modern era","volume":"28","author":"Evens","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.tcm.2014.08.004_bib38","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.healun.2011.12.006","article-title":"Prevalence and prognostic value of cardiac allograft vasculopathy 1 year after heart transplantation according to the ISHLT recommended nomenclature","volume":"31","author":"Prada-Delgado","year":"2012","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.tcm.2014.08.004_bib39","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1161\/01.RES.0000246086.93555.f3","article-title":"Allograft vasculopathy versus atherosclerosis","volume":"99","author":"Rahmani","year":"2006","journal-title":"Circ Res"},{"key":"10.1016\/j.tcm.2014.08.004_bib40","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1399-0012.2010.01307.x","article-title":"Cardiac allograft vasculopathy: current knowledge and future direction","volume":"25","author":"Colvin-Adams","year":"2011","journal-title":"Clin Transplant"},{"key":"10.1016\/j.tcm.2014.08.004_bib41","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1016\/j.transproceed.2011.06.002","article-title":"Prevalence of cardiac allograft vasculopathy assessed with coronary angiography versus coronary vascular ultrasound and virtual histology","volume":"43","author":"Torres","year":"2011","journal-title":"Transplant Proc"},{"key":"10.1016\/j.tcm.2014.08.004_bib42","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/j.jacc.2005.02.035","article-title":"Multicenter intravascular ultrasound validation study among heart transplant recipients: outcomes after five years","volume":"45","author":"Kobashigawa","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2014.08.004_bib43","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1161\/01.CIR.100.5.509","article-title":"Diagnostic and prognostic value of serial dobutamine stress echocardiography for noninvasive assessment of cardiac allograft vasculopathy: a comparison with coronary angiography and intravascular ultrasound","volume":"100","author":"Spes","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2014.08.004_bib44","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1016\/j.jacc.2014.01.071","article-title":"Coronary computed tomography angiography for the detection of cardiac allograft vasculopathy: a meta-analysis of prospective trials","volume":"63","author":"Wever-Pinzon","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2014.08.004_bib45","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.healun.2013.02.005","article-title":"Optical coherence tomography for characterization of cardiac allograft vasculopathy after heart transplantation (OCTCAV study)","volume":"32","author":"Khandhar","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.tcm.2014.08.004_bib46","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.jacc.2013.07.119","article-title":"Multiparametric cardiovascular magnetic resonance assessment of cardiac allograft vasculopathy","volume":"63","author":"Miller","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2014.08.004_bib47","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/j.healun.2005.02.009","article-title":"Ten-year follow-up of a randomized trial of pravastatin in heart transplant patients","volume":"24","author":"Kobashigawa","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.tcm.2014.08.004_bib48","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1056\/NEJM199301213280303","article-title":"A preliminary study of diltiazem in the prevention of coronary artery disease in heart-transplant recipients","volume":"328","author":"Schroeder","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tcm.2014.08.004_bib49","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.amjcard.2011.04.014","article-title":"Comparison of drug-eluting versus bare metal stents in cardiac allograft vasculopathy","volume":"108","author":"Tremmel","year":"2011","journal-title":"Am J Cardiol"}],"container-title":["Trends in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1050173814000978?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1050173814000978?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,30]],"date-time":"2018-09-30T09:00:07Z","timestamp":1538298007000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1050173814000978"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":49,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S1050173814000978"],"URL":"https:\/\/doi.org\/10.1016\/j.tcm.2014.08.004","relation":{},"ISSN":["1050-1738"],"issn-type":[{"value":"1050-1738","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"State of the art: Cardiac transplantation","name":"articletitle","label":"Article Title"},{"value":"Trends in Cardiovascular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tcm.2014.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}